NMDA R, NR1 Subunit Antibody (1031915) [PE]
Novus Biologicals, part of Bio-Techne | Catalog # FAB10655P
Conjugate
Catalog #
Key Product Details
Species Reactivity
Mouse
Applications
Immunocytochemistry, Intracellular Staining by Flow Cytometry
Label
PE (Excitation = 488 nm, Emission = 575 nm)
Antibody Source
Monoclonal Rat IgG2A Clone # 1031915
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant mouse GRIN1/NMDAR1
Met1-Gln559
Met1-Gln559
Specificity
Detects mouse GRIN1/NMDAR1 in direct ELISAs.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2A
Applications for NMDA R, NR1 Subunit Antibody (1031915) [PE]
Application
Recommended Usage
Immunocytochemistry
Optimal dilutions of this antibody should be experimentally determined.
Intracellular Staining by Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from cell culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: NMDA R, NR1 Subunit
Long Name
Glutamate Receptor, Ionotropic, N-Methyl-D-Aspartate, Subunit 1
Alternate Names
GluN1, MRD8, NDHMSD, NDHMSR;NMD-R1, NMDA R, NR1 Subunit, NMDA1, NMDAR1, NMD-R1, NR1
Additional NMDA R, NR1 Subunit Products
Product Documents for NMDA R, NR1 Subunit Antibody (1031915) [PE]
Product Specific Notices for NMDA R, NR1 Subunit Antibody (1031915) [PE]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...